相关实验视频
Updated: Jul 10, 2025

09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.4K
长非编码RNA MALAT1 作为竞争的内源RNA,通过在高血压中使用miR-145-5p/HK2进行海绵化来调节血管重塑
Jiangyong Yang1, Guojun Jiang2, Ling Huang1
1Department of Cardiology, Ganzhou Hospital of Guangdong Provincial People's Hospital, Ganzhou Municipal Hospital, Ganzhou, Jiangxi, China.
Clinical and experimental hypertension (New York, N.Y. : 1993)
|November 27, 2023
概括
长非编码RNAMALAT1通过与miR-145-5p和HK2.2相互作用来调节高血压中的血管重塑. 这个轴影响血管光滑肌肉细胞的增殖和迁移,提供潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 心血管研究研究心血管研究
- 遗传学 是一个遗传学.
背景情况:
- 长非编码RNAs (LncRNAs) 是血管重塑等疾病的关键调节者.
- LncRNA MALAT1 影响血管光滑肌肉细胞 (VSMC) 功能.
- 高血压涉及病态的血管改造.
研究的目的:
- 研究MALAT1在高血压引起的血管改造中的作用.
- 阐明涉及MALAT1,微RNA和VSMC中的基因的调节途径.
主要方法:
- 定量实时PCR测量基因表达.
- 细胞增殖和迁移的测试.
- 生物信息学分析, luciferase 记者测定和 RNA 免疫沉以确认分子相互作用.
主要成果:
- 在高血压的大动脉光滑肌中,MALAT1的表达被上调.
- 马拉特1敲击抑制Ang II诱导的VSMC的扩散,迁移和表型转变.
- MALAT1 与 miR-145-5p 相互作用, miR-145-5p 针对 HK2 mRNA; 这个轴调节 VSMC 的行为.
结论:
- MALAT1/miR-145-5p/HK2轴是高血压中血管重塑的关键调节器.
- 针对这一轴可能为高血压血管疾病提供治疗策略.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
748
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
748
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
654
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
654
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Vasodilators
537
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
537

